Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc. (Nasdaq: TCMD), which does business as Tactile Medical, develops and provides medical devices for at-home treatment of chronic diseases. Its products serve patients with lymphedema and chronic venous insufficiency, including people whose lymphedema is associated with cancer treatment,… From the company’s description.
Over the twelve months to Sep 30, 2026, Tactile Systems Technology, Inc. reported revenue of $356.42M, up 14.4% from a year earlier, and net income of $23.82M. Its operating margin was 9.4%, and operations generated $32.19M in cash. In fiscal 2025, it reported revenue of $329.52M, up 12.5% from fiscal 2024, and net income of $19.09M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Tactile Systems Technology, Inc. does
In the company’s own words
Tactile Systems Technology, Inc. (Nasdaq: TCMD), which does business as Tactile Medical, develops and provides medical devices for at-home treatment of chronic diseases. Its products serve patients with lymphedema and chronic venous insufficiency, including people whose lymphedema is associated with cancer treatment, as well as patients with chronic respiratory conditions. The company sells and rents its Flexitouch Plus, Entre Plus and Nimbl compression systems through a direct-to-patient and provider model, supporting patient referrals, insurance claims, delivery and training. Its AffloVest airway-clearance vest is sold to durable medical equipment providers for use by patients with conditions including bronchiectasis and neuromuscular disorders. In 2025, lymphedema products generated $278.4 million, or 84% of revenue, while AffloVest generated $51.1 million, or 16%. The company reported revenue of $329.5 million for the year ended December 31, 2025, and served more than 84,000 patients with compression therapy devices that year. Tactile acquired the AffloVest product line in 2021. Its website is www.tactilemedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- MINNEAPOLIS, MN
- Fiscal year end
- December
- CIK
- 1027838
- SIC
- 3841
Financial performance, year by year
Fiscal 2016–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Tactile Systems Technology, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Tactile Systems Technology, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Tactile Systems Technology, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Tactile Systems Technology, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Tactile Systems Technology, Inc.'s last four quarterly filings that the numbers alone won't show?”